Arialief Supplement: Vitamins Reviews and Complaints for Neuropathic Pain
HONOLULU, April 09, 2025 (GLOBE NEWSWIRE) -- Arialief is a premium dietary supplement specifically designed to target the root causes...
Brain
Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
NDA Submission Anticipated Q2 Calendar 2025PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics...
AFFOA Names Nuream and Z-Polymers the New Awardees of the Product Accelerator for Advanced Fabrics 2.0
CAMBRIDGE, Mass., April 8, 2025 /PRNewswire/ -- Advanced Functional Fabrics of America, Inc. (AFFOA) proudly announces Nuream and Z-Polymers as...
Brainomix Advances Stroke Care with Landmark FDA Clearance
Brainomix 360 unlocks expert-level insights from universally available non-contrast CT scans, helping stroke networks expand access to life-changing treatmentsOXFORD, England...
Kandu Health and Neurolutions Merge to Form Kandu, Inc., a New Leader in Stroke Recovery
Kandu, Inc. Announces $30 Million Financing to Advance Stroke Recovery and Rehabilitation VAN NUYS, Calif.--(BUSINESS WIRE)--KanduTM Health, Inc. and Neurolutions,...
Rapid Dose Therapeutics Provides Update on the Clinical Trial Development and the Commitment to NFL Funded Cannabinoid Research
Burlington, Ontario--(Newsfile Corp. - April 8, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian biotech...
Quibim Announces New Board of Directors To Promote Growth And Strategic Expansion
NEW YORK & VALENCIA, Spain & CAMBRIDGE, England--(BUSINESS WIRE)--#AIinHealthcare--Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased...
CAS and Cleveland Clinic collaborate to accelerate research through advanced AI and quantum computing
COLUMBUS, Ohio, April 7, 2025 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific content and...
2025 ZGC Forum: Gala for Global Sci-tech Cooperation
BEIJING, April 7, 2025 /PRNewswire/ -- A report from Science and Technology Daily: The 2025 Zhongguancun Forum Annual Conference (2025 ZGC...
Cala Presents Multiple Clinical Studies Demonstrating Impact of Transcutaneous Afferent Patterned Stimulation (TAPS) Therapy in Essential Tremor (ET) Patients at the American Academy of Neurology (AAN)
SAN MATEO, Calif., April 7, 2025 /PRNewswire/ -- Cala, the bioelectronic medicine leader, who recently raised an oversubscribed growth financing round...
Make Time Wellness Announces Launch of Award-Winning Products at The Vitamin Shoppe
New Wellness Solutions Available Starting April 2025, Empowering Women to Prioritize Their Brain Health LOS ANGELES, April 7, 2025 /PRNewswire/...
UK Pilot launched to detect early signs of dementia & improve brain health
The Pilot Program uses a unique "Human + AI" (HAI) model to interact with patients & monitor progress. LONDON, April...
European Commission approves subcutaneous RYBREVANT®▼ (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
Subcutaneous (SC) amivantamab offers patients greater convenience, reducing administration time from hours to minutes and with a five-fold reduction in...
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells...
Lenire Supports Veterans by Sponsoring Hearoes Tour
Lenire proudly sponsors the 10th Annual LexCare Hearing Foundation Hearoes Tour.Lenire is a treatment option for 3.2m veterans living with...
Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
ATTENTION-AD trial data through 192 weeks presented at AD/PDTM 2025 Conference Prespecified delayed-start analysis indicate disease-modifying effect of oral blarcamesine...
Arialief Reviews (SHOCKING REPORT!) Is This Sciatic Nerve Relief Supplement Safe or Overhyped Hoax?
HONOLULU, Hawaii, April 05, 2025 (GLOBE NEWSWIRE) -- Arialief is nutritional support specifically designed to offer sciatic nerve relief. It...
University of Arizona Study Finds Openwater’s Open-LIFU 2.0 Device Achieves Significant Depression Symptom Reduction After Less Than Two Hours Total Treatment Time
Clinical Trial Utilizing Low-Intensity Transcranial Focused Ultrasound Pulses to Key Brain Region Shows Notable Reduction in Negative Thoughts, Improved Well-being,...
Cumulus Neuroscience Presents Data at AD/PD™ 2025 Annual Meeting
Validation data presented at the 2025 Alzheimer's & Parkinson's Diseases (AD/PD) Conference confirms two novel NeuLogiq® Platform endpoints show greater...
Sensi.AI and Teepa Snow: In the Moment Care Coaching Is Here
Sensi brings renowned dementia and aging care expert Teepa Snow's proven strategies to the point of care—blending AI with human...